Cargando…

Aspirin-triggered 15-epi-lipoxin A(4) predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test

Inhibition of cyclooxygenase (COX)-2 increases cardiovascular deaths. Identifying a biomarker of COX-2 is desirable but difficult, since COX-1 and COX-2 ordinarily catalyze formation of an identical product, prostaglandin H(2). When acetylated by aspirin, however, COX-2 (but not COX-1) can form 15(R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirkby, Nicholas S., Chan, Melissa V., Lundberg, Martina H., Massey, Karen A., Edmands, William M. B., MacKenzie, Louise S., Holmes, Elaine, Nicolaou, Anna, Warner, Timothy D., Mitchell, Jane A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Federation of American Societies for Experimental Biology 2013
Materias:	Research Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973905/ https://www.ncbi.nlm.nih.gov/pubmed/23792301 http://dx.doi.org/10.1096/fj.12-215533

Ejemplares similares

Lipid-Derived Mediators in Endogenous Anti-Inflammation and Resolution: Lipoxins and Aspirin-Triggered 15-epi-Lipoxins
por: Serhan, Charles N., et al.
Publicado: (2002)

Lipoxin and Aspirin-Triggered Lipoxins
por: Romano, Mario
Publicado: (2010)

Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing
por: Svensson, Camilla I., et al.
Publicado: (2007)

Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1
por: Rauzi, Francesca, et al.
Publicado: (2016)

15-epi-lipoxin A(4)–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation
por: Paul-Clark, Mark J., et al.
Publicado: (2004)

Aspirin-triggered 15-Epi-Lipoxin A(4) (LXA(4)) and LXA(4) Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors
por: Takano, Tomoko, et al.
Publicado: (1997)

Release of cyclooxygenase-2 and lipoxin A(4) from blood leukocytes in aspirin-exacerbated respiratory disease
por: Rozsasi, Ajnacska, et al.
Publicado: (2016)

Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines
por: Hu, Shan, et al.
Publicado: (2012)

Aspirin-triggered 15-epi-lipoxin A(4) signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation
por: Petri, Marcelo H., et al.
Publicado: (2015)

Activation of Lipoxin a(4) Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation
por: Chiang, Nan, et al.
Publicado: (2000)

Lovastatin Decreases Acute Mucosal Inflammation Via 15-epi-Lipoxin A(4)
por: Planagumà, Anna, et al.
Publicado: (2010)

Lipoxin (LX)A(4) and Aspirin-triggered 15-epi-LXA(4) Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis
por: Hachicha, Mohamed, et al.
Publicado: (1999)

Lipoxin A(4) and 15-Epi-Lipoxin A(4) Protect against Experimental Cerebral Malaria by Inhibiting IL-12/IFN-γ in the Brain
por: Shryock, Nathaniel, et al.
Publicado: (2013)

Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6
por: Machado, Fabiana S., et al.
Publicado: (2008)

Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6
por: Machado, Fabiana S., et al.
Publicado: (2009)

Aspirin-triggered lipoxin A(4 )attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells
por: Wang, Yan-Ping, et al.
Publicado: (2011)

Resolution Agonist 15-epi-Lipoxin A(4) Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing
por: Kain, Vasundhara, et al.
Publicado: (2017)

Protective Role of Acetylsalicylic Acid in Experimental Trypanosoma cruzi Infection: Evidence of a 15-epi-Lipoxin A(4)-Mediated Effect
por: Molina-Berríos, Alfredo, et al.
Publicado: (2013)

Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin
por: Campos-Estrada, Carolina, et al.
Publicado: (2015)

15-epi-lipoxin A(4) reduces the mortality of prematurely born pups in a mouse model of infection-induced preterm birth
por: Rinaldi, S.F., et al.
Publicado: (2015)

The effect of lipoxin A4 on E. coli LPS-induced osteoclastogenesis
por: Ali, Muhanad, et al.
Publicado: (2020)

The effect of low-dose aspirin on aspirin triggered lipoxin, interleukin 1 beta, and prostaglandin E2 levels in periapical fluid: a double-blind randomized clinical trial
por: Khoshbin, Elham, et al.
Publicado: (2023)

Novel Biphasic Role of LipoxinA(4) on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts
por: Zheng, Shengxing, et al.
Publicado: (2011)

Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system
por: Mitchell, Jane A, et al.
Publicado: (2018)

Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE(2), 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders
por: Blanchard, Helene C., et al.
Publicado: (2015)

Lipoxin Receptors
por: Romano, Mario, et al.
Publicado: (2007)

Lipoxin A4 promotes autophagy and inhibits overactivation of macrophage inflammasome activity induced by Pg LPS
por: Zhao, Jie, et al.
Publicado: (2021)

Sex differences in early transcriptomic responses to oxidative stress in the copepod Tigriopus californicus
por: Li, Ning, et al.
Publicado: (2020)

Exogenous Pathogen and Plant 15-Lipoxygenase Initiate Endogenous Lipoxin A(4) Biosynthesis
por: Bannenberg, Gerard L., et al.
Publicado: (2004)

Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer
por: Martin-Martin, Antonia, et al.
Publicado: (2019)

Impact of Aspirin Eugenol Ester on Cyclooxygenase-1, Cyclooxygenase-2, C-Reactive Protein, Prothrombin and Arachidonate 5-Lipoxygenase in Healthy Rats
por: Ma, Ning, et al.
Publicado: (2017)

Lipoxin A4 and Platelet Activating Factor Are Involved in E. coli or LPS-Induced Lung Inflammation in CFTR-Deficient Mice
por: Wu, Haiya, et al.
Publicado: (2014)

Endothelial cyclooxygenase-1 paradoxically drives local vasoconstriction and atherogenesis despite underpinning prostacyclin generation
por: Mitchell, Jane A., et al.
Publicado: (2021)

Lipoxins: nature’s way to resolve inflammation
por: Chandrasekharan, Jayashree A, et al.
Publicado: (2015)

Cyclooxygenase Inhibitors, Aspirin and Ibuprofen, Inhibit MHC-restricted Antigen Presentation in Dendritic Cells
por: Kim, Hyun-Jin, et al.
Publicado: (2010)

The LPS trigger system
por: Benotto, F, et al.
Publicado: (1996)

Antiplatelet effects of aspirin vary with level of P2Y(12) receptor blockade supplied by either ticagrelor or prasugrel
por: KIRKBY, N S, et al.
Publicado: (2011)

Aspirin has little additional anti-platelet effect in healthy volunteers receiving prasugrel
por: LEADBEATER, P D M, et al.
Publicado: (2011)

LC-MS/MS Confirms That COX-1 Drives Vascular Prostacyclin Whilst Gene Expression Pattern Reveals Non-Vascular Sites of COX-2 Expression
por: Kirkby, Nicholas S., et al.
Publicado: (2013)

Lipoxins as biomarkers of lupus and other inflammatory conditions
por: Das, Undurti N
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ld288aas3pblcdmi32finoouse